Waters Corporation Shows Stability in a Turbulent Market Environment Thanks to its Focus on Pharma and Biotech. KeyBanc Sees 27% Upside Potential.

The stock of Waters Corporation (WAT) remains quite stable in a challenging market environment. It is a provider of analytical laboratory instruments and software solutions. The largest market segment (Pharma) of Waters grew by 10% in the last quarter, driven by a recovery in investments across Europe, Asia, and America, as well as strong demand from large pharmaceutical companies, contract manufacturers (CDMOs), and generic drug manufacturers in India. The company experiences strong demand in areas such as GLP-1 testing (e.g., for diabetes medications),...